Transfer and Metabolism of Cortisol by the Isolated Perfused Human Placenta
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Context: Fetal overexposure to glucocorticoids in utero is associated with fetal growth restriction and is postulated to be a key mechanism linking suboptimal fetal growth with cardiovascular disease in later life. Objective: To develop a model to predict maternal-fetal glucocorticoid transfer. We hypothesized placental 11-β-hydroxysteroid dehydrogenase-type 2 (11β-HSD2) would be the major rate-limiting step in maternal cortisol transfer to the fetus. Design: We used a deuterated cortisol tracer in the ex vivo placental perfusion model, in combination with computational modeling, to investigate the role of interconversion of cortisol and its inactive metabolite cortisone on transfer of cortisol from mother to fetus. Participants: Term placentas were collected from five women with uncomplicated pregnancies, at elective caesarean delivery. Intervention: Maternal artery of the isolated perfused placenta was perfused with D4-cortisol. Main Outcome Measures: D4-cortisol, D3-cortisone, and D3-cortisol were measured in maternal and fetal venous outflows. Results: D4-cortisol, D3-cortisone, and D3-cortisol were detected and increased in maternal and fetal veins as the concentration of D4-cortisol perfusion increased. D3-cortisone synthesis was inhibited when 11-β-hydroxysteroid dehydrogenase (11β-HSD) activity was inhibited. At the highest inlet concentration, only 3.0% of the maternal cortisol was transferred to the fetal circulation, whereas 26.5% was metabolized and 70.5% exited via the maternal vein. Inhibiting 11β-HSD activity increased the transfer to the fetus to 7.3% of the maternal input, whereas 92.7% exited via the maternal vein. Conclusions: Our findings challenge the concept that maternal cortisol diffuses freely across the placenta and confirm that 11β-HSD2 acts as a major "barrier" to cortisol transfer to the fetus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure
Benediktsson, R., Calder, A. A., Edwards, C. R. W., & Seckl, J. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1230939.x · Cited by 536
Reynolds, R. M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.012 · Cited by 497
Self-citationMaternal prenatal anxiety and downregulation of placental 11β-HSD2
O’Donnell, K. J., Bugge Jensen, A., Freeman, L., Khalife, N., O’Connor, T. G., & Glover, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.014 · Cited by 449 · cited 1×
“It is not known what the capacity of 11b-HSD2 would be if exposed to high levels of maternal glucocorticoids for more prolonged periods, but studies have demonstrated that 11bHSD2 mRNA and activity is downregulated by maternal stress (23) and inflammatory diseases (22).”
BackgroundA longitudinal study of plasma and urinary cortisol in pregnancy and postpartum
Jung, C., Ho, J. T., Torpy, D. J., Rogers, A., Doogue, M., Lewis, J. G., Czajko, R. J., & Inder, W. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2395 · Cited by 394
Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action
Hammond, G. L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0070 · Cited by 356
Brown, R. W., Chapman, K. E., Edwards, C. R., & Seckl, J. R. (1993) · Endocrinology · doi:10.1210/endo.132.6.8504762 · Cited by 271
Krozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608280 · Cited by 252 · cited 1×
“localized to the syncytiotrophoblast (7), which is the”
BackgroundSun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., & Gibb, W. (2006) · Placenta · doi:10.1016/j.placenta.2005.05.007 · Cited by 223
Reconciling the nutritional and glucocorticoid hypotheses of fetal programming
Cottrell, E. C., Holmes, M. C., Livingstone, D. E., Kenyon, C. J., & Seckl, J. R. (2012) · The FASEB Journal · doi:10.1096/fj.12-203489 · Cited by 102 · cited 1×
“nal glucocorticoids passing to the fetus in rodents (9) and”
BackgroundMaternal cortisol and offspring birthweight: results from a large prospective cohort study
Goedhart, G., Vrijkotte, T. G. M., Roseboom, T. J., van der Wal, M. F., Cuijpers, P., & Bonsel, G. J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.10.003 · Cited by 96 · cited 1×
“Although technically challenging, functional studies using early and midgestation tissue would be of value, as cortisol exposure at earlier gestations is thought to influence fetal growth (36, 37).”
Background
Research works printed but not linked: 26
- Stewart, 1995, Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis, J Clin Endocrinol Metab, 80, 885
- Beitins, 1973, The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term, Pediatr Res, 7, 509, 10.1203/00006450-197305000-00004 · DOI · Paper page
- Brown, 1996, The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development, Endocrinology, 137, 794, 10.1210/endo.137.2.8593833 · doi:10.1210/endo.137.2.8593833 · Paper page
- Sun, 1997, Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes, J Clin Endocrinol Metab, 82, 300
- Reynolds, 2015, Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity, Psychol Med, 45, 2023, 10.1017/S003329171400316X · DOI · Paper page
- Räikkönen, 2015, Maternal depressive symptoms during pregnancy, placental expression of genes regulating glucocorticoid and serotonin function and infant regulatory behaviors, Psychol Med, 45, 3217, 10.1017/S003329171500121X · DOI · Paper page
- Sengers, 2010, Computational modelling of amino acid transfer interactions in the placenta, Exp Physiol, 95, 829, 10.1113/expphysiol.2010.052902 · doi:10.1113/expphysiol.2010.052902
- Panitchob, 2015, Computational modelling of amino acid exchange and facilitated transport in placental membrane vesicles, J Theor Biol, 365, 352, 10.1016/j.jtbi.2014.10.042 · doi:10.1016/j.jtbi.2014.10.042
- Perazzolo, 2017, The influence of placental metabolism on fatty acid transfer to the fetus, J Lipid Res, 58, 443, 10.1194/jlr.P072355 · doi:10.1194/jlr.p072355
- Schneider, 1972, Transfer across the perfused human placenta of antipyrine, sodium and leucine, Am J Obstet Gynecol, 114, 822, 10.1016/0002-9378(72)90909-X · DOI · Paper page
- Cleal, 2007, Modification of fetal plasma amino acid composition by placental amino acid exchangers in vitro, J Physiol, 582, 871, 10.1113/jphysiol.2007.130690 · DOI
- Andrew, 2002, Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol, J Clin Endocrinol Metab, 87, 277
- Stirrat, 2016, Decreased maternal hypothalamic-pituitary-adrenal axis activity in very severely obese pregnancy: associations with birthweight and gestation at delivery, Psychoneuroendocrinology, 63, 135, 10.1016/j.psyneuen.2015.09.019 · DOI
- Panitchob, 2016, Computational modelling of placental amino acid transfer as an integrated system, Biochim Biophys Acta, 1858, 1451, 10.1016/j.bbamem.2016.03.028 · DOI
- Murphy, 2003, Alterations in human placental 11beta-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour, Placenta, 24, 739, 10.1016/S0143-4004(03)00103-6 · DOI
- Räikkönen, 2009, Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children, Am J Epidemiol, 170, 1137, 10.1093/aje/kwp272 · DOI · Paper page
- Räikkönen, 2017, Maternal licorice consumption during pregnancy and pubertal, cognitive, and psychiatric outcomes in children, Am J Epidemiol, 185, 317, 10.1093/aje/kww172 · DOI
- St-Pierre, 2000, Expression of members of the multidrug resistance protein family in human term placenta, Am J Physiol Regul Integr Comp Physiol, 279, R1495, 10.1152/ajpregu.2000.279.4.R1495 · DOI · Paper page
- Yeboah, 2006, Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor, Can J Physiol Pharmacol, 84, 1251, 10.1139/y06-078 · DOI · Paper page
- Iqbal, 2012, Placental drug transporters and their role in fetal protection, Placenta, 33, 137, 10.1016/j.placenta.2012.01.008 · DOI
- Kalabis, 2005, Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection, Biol Reprod, 73, 591, 10.1095/biolreprod.105.042242 · DOI · Paper page
- Pascolo, 2003, Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells, Biochem Biophys Res Commun, 303, 259, 10.1016/S0006-291X(03)00327-9 · DOI
- Huang, 2013, Increased placental phospholipid levels in pre-eclamptic pregnancies, Int J Mol Sci, 14, 3487, 10.3390/ijms14023487 · DOI
- Phillips, 2014, Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation, BMC Pregnancy Childbirth, 14, 241, 10.1186/1471-2393-14-241 · DOI
- Hughes, 2012, Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo, Diabetes, 61, 1357, 10.2337/db11-1345 · DOI · Paper page
- Baibazarova, 2013, Influence of prenatal maternal stress, maternal plasma cortisol and cortisol in the amniotic fluid on birth outcomes and child temperament at 3 months, Psychoneuroendocrinology, 38, 907, 10.1016/j.psyneuen.2012.09.015 · DOI · Paper page
Cited by
Prenatal developmental origins of future psychopathology: mechanisms and pathways
Monk, C., Lugo-Candelas, C., & Trumpff, C. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095539 · Cited by 388
Chatuphonprasert, W., Jarukamjorn, K., & Ellinger, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01027 · Cited by 269
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Argyraki, M., Damdimopoulou, P., Chatzimeletiou, K., Grimbizis, G. F., Tarlatzis, B. C., Syrrou, M., & Lambropoulos, A. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz025 · Cited by 86
Scheinost, D., Spann, M. N., McDonough, L., Peterson, B. S., & Monk, C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0677-0 · Cited by 73
Metadata
- Authors
- Stirrat, L. I., Sengers, B. G., Norman, J. E., Homer, N. Z. M., Andrew, R., Lewis, R. M., & Reynolds, R. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-11-16
- Volume
- 103
- Issue
- 2
- Pages
- 640-648
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2770217230
- Cited by
- 98
- References
- 11
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Medical Research Council (MR/N022556/1)
- British Heart Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.